Dépêches

US Department of Homeland Security, American Airlines Cargo and Pfizer Discuss TSA Cargo Screening Program and Requirements for Safely Shipping Pharmaceuticals

Dépèche transmise le 5 août 2009 par Business Wire

US Department of Homeland Security, American Airlines Cargo and Pfizer Discuss TSA Cargo Screening Program and Requirements for Safely Shipping Pharmaceuticals

US Department of Homeland Security, American Airlines Cargo and Pfizer Discuss TSA Cargo Screening Program and Requirements for Safely Shipping Pharmaceuticals

PHILADELPHIA--(BUSINESS WIRE)--The US Department of Homeland Security, American Airlines Cargo and Pfizer will participate in a panel discussion on new TSA cargo security requirements during the 7th Annual Cold Chain Distribution for Pharmaceuticals (www.coldchainpharma.com), organized by the International Quality and Productivity Center (IQPC) and held September 21-24, 2009 at the Pennsylvania Convention Center in Philadelphia, PA.

Edward J. Kelly, General Manager for Air Cargo, Transportation Security Administration (TSA) of the US Department of Homeland Security will present a keynote on meeting US security standards and qualifying for the TSA screening program. The TSA Cargo Screening Program requires that pharmaceutical shipments on passenger planes are pre-screened and calls for biopharmaceutical organizations to be qualify for the program in 2010. Edward Kelly’s keynote addresses the program’s background, including pending deadlines, proving the chain of custody and specific requirements for freight forwarders.

Following the keynote is a panel discussion sponsored by American Airlines Cargo, entitled “Navigating the New TSA Requirements – Why a Layered Risk-Based Approach to Air Cargo Security Provides the Best Model for Safely Shipping Pharmaceuticals”. In addition to Edward Kelly, other panelists include David R. Brooks, President of American Airlines Cargo and Brad Elrod, Senior Manager, Global Logistics Security at Pfizer.

Specific questions addressed during the panel include:

  • Why does a layered risk-based approach make sense?
  • What innovative steps are being taken to adapt to a 100% screening environment?
  • How will supply chain value be impacted for pharmaceutical shipments?

Other participating organizations include: PDA, MHRA, Health Canada, American Red Cross, Wyeth, Johnson & Johnson, Schering-Plough, McKesson Canada Corporation, Seattle Genetics, Eli Lilly & Company and Merial Animal Health.

The audience for this event includes senior representatives from pharmaceutical, wholesale and distribution companies with responsibilities in quality assurance, transportation, packaging, trade relations, global/domestic supply, regulatory affairs and warehouse management.

For additional information, visit www.coldchainpharma.com or contact Abby Lombardi at +1 212-885-2660 or abby.lombardi@iqpc.com.

About IQPC

IQPC (www.iqpc.com) provides business executives with tailored practical conferences, large-scale events, topical seminars and in-house training programs. Producing over 1,500 events annually around the world, IQPC continues to grow and has offices in cities across six continents including: Berlin, Dubai, London, New York, Sao Paulo, Singapore, Stockholm, Sydney, and Toronto.

Business Wire

Les plus belles photos d'avions
Boeing 737-36Q/WL (YL-BBX) Sukhoi Superjet 100-95B (RA-89028) Cessna 525 CitationJet CJ1 (SE-RGX) Bombardier CSeries CS300 (BD-500-1A11) (YL-CSC) PZL-Mielec M-28B1TD Bryza 1TD (1117) Boeing 737-522 (YL-BBN)